Scott Hensley
-
This is the first new drug approved for Alzheimer's disease since 2003. It's the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer's disease. -
The Food and Drug Administration gave Johnson & Johnson's vaccine the green light for emergency use Saturday, a day after a panel of advisers to the agency endorsed it in a unanimous vote.
-
The vaccine did better at preventing disease in the U.S. – 72% — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.
-
Novavax says its COVID-19 vaccine is 89% effective at preventing illness, according to an interim analysis of a U.K. study. But the vaccine wasn't as effective against some viral variants.
-
Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.
-
The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.
-
The president, who is being treated for COVID-19, has been downplaying the severity of the disease. He said falsely that, compared with the flu, COVID-19 is "in most populations far less lethal."
-
The president, who tested positive for the coronavirus, "has completed his first dose and is resting comfortably," physician Sean Conley said in a statement.
-
The president says 50,000 could die from the flu. So far this season, the Centers for Disease Control and Prevention says, it's at least 23,000 with an upper estimate as high as 59,000.
-
The Federal Reserve on Monday announced several policies designed to strengthen markets during the coronavirus crisis. Still, stocks are down, minutes after the opening bell.
